Home / World Marketplace / Archive by category Global Health & Biotech (Page 49)

Archive by category Global Health & Biotech

Essential Pharma announces €900 million recapitalisation through a Gyrus Capital Continuation Vehicle led by AlpInvest and new strategic financing from Sixth Street

Provides significant resources to build on diversified portfolio of established and rare disease medicines Egham, UK – 12 December 2024 – Essential Pharma (“Essential” or “the Company”), an international specialty pharma group focused on ensuring that patients have access to low volume, clinically differentiated, niche pharmaceutical products across key therapeutic areas, today announces the completion of [...]

Io Therapeutics, Inc., Announces Presentation of Data from Studies of Its RAR Gamma Agonist Compound IRX5010 in Treatment of a Mouse Model of Triple Negative Breast Cancer, Demonstrating Combination Treatment Effects with an Anti-PDL-1 Monoclonal Antibody Checkpoint Inhibitor

The combination treatment resulted in increased numbers of anti-cancer tumor-infiltrating T-cells; decreased numbers of anti-cancer response inhibiting tumor-infiltrating myeloid derived suppressor cells; and substantial 84% inhibition of tumor growth SPRING, Texas, Dec. 11 (Korea Bizwire) — Io Therapeutics, Inc., presented results from studies done in a mouse model of triple negative breast cancer with the [...]

Teva Announces New Patient Access Program with Direct Relief to Provide Access to Inhalers for Uninsured Patients

Teva to provide two generic inhaler products to Direct Relief for its network of free and charitable clinics The program, launching this month, will run for a minimum of three years PARSIPPANY, N.J., Dec. 11, 2024 (Korea Bizwire) – Teva Pharmaceuticals, Inc., a U.S. affiliate of Teva Pharmaceutical Industries Ltd. (NYSE and TASE: TEVA), announced today the launch of a new patient access [...]

GEn1E Lifesciences appoints François Nader, MD as Chair of its Board of Directors

Former CEO of NPS Pharma brings strong biotech expertise to further accelerate GEn1E’s development and commercialization of dual signal modulators as novel precision therapies PALO ALTO, Calif., Dec. 11, 2024 (Korea Bizwire) – GEn1E Lifesciences (GEn1E), a clinical-stage, Phase 2 company, focused on accelerating novel therapies for inflammatory and rare diseases using machine learning, is [...]

AiViva Biopharma Receives FDA Clearance to Administer AIV001 in Facial Skin by Intradermal Injection for Nonmelanoma Skin Cancer

AIV001 is currently in development for evaluation in Superficial and Nodular Superficial Basal Cell Carcinoma (sBCC and nBCC) COSA MESA, Calif., Dec. 09, 2024 (Korea Bizwire) – AiViva Biopharma Inc., a clinical-stage biotechnology company, announced the receipt of FDA clearance for testing AIV001 (axitinib) by intradermal injection with their formulation in facial skin. AIV001 is [...]

Teva Presents Positive Efficacy and Safety Data of AJOVY® (fremanezumab) for the Prevention of Episodic Migraine in Children and Adolescents from Phase 3 SPACE Trial

AJOVY® (fremanezumab) significantly reduced monthly migraine days (MMD) and monthly headache days (MHD) versus placebo over a 12-week period in pediatric patients aged 6-17 years1 Efficacy consistent with fremanezumab pivotal Phase 3 and Real-World Evidence studies in adults with no new emergent safety signals observed Full data presented as a late breaker at European Headache Congress (EHC) 4-7 December in [...]

Philips aims to advance cardiac MRI technology through AI-driven research

December 3, 2024 Collaboration intends to leverage proprietary AI technology from Philips and Mayo Clinic to target breakthroughs in ease-of-use and efficiency to bring high-quality diagnostic MRI and better care to more patients with heart disease Amsterdam, the Netherlands and Chicago, USA – Royal Philips (NYSE: PHG, AEX: PHIA) and Mayo Clinic today announced a research collaboration aimed at advancing [...]

Canon Medical Informatics Selected by Major Non-Profit Health System to Standardize Advanced Visualization Across 25+ Locations

MINNETONKA, Minn., Dec. 03, 2024 (Korea Bizwire) – Canon Medical Informatics, Inc. today announced that a leading non-profit health system in the Mid-Atlantic region has chosen Canon’s Vitrea® Advanced Visualization enterprise platform to consolidate its 3D imaging capabilities across more than 25 sites. This transition from a multi-vendor setup to a unified, integrated solution will help [...]

Canon Medical Informatics Selected by Leading U.S. Health System to Standardize 3D Processing Capabilities in the Cloud Using Vitrea Advanced Visualization Platform

MINNETONKA, Minn., Dec. 02, 2024 (Korea Bizwire) – Canon Medical Informatics, Inc. has been selected by a leading U.S. health system to standardize advanced imaging capabilities across 6 sites using the Vitrea Advanced Visualization enterprise platform. By leveraging their privately managed cloud infrastructure, the health system achieves scalable, secure, and cost-efficient access to cutting-edge imaging [...]

Philips optimizes CT workflows with in-house AI, launches CT 5300 in North America at #RSNA2024

December 1, 2024 Philips CT 5300 combines innovative hardware, software, and artificial intelligence to make high-quality screening, diagnostic, and interventional imaging accessible to more patients, including reading support with Automated AI-enabled Philips Advanced Visualization Workspace applications Philips collaborates with Annalise.ai to evaluate streamlining workflows to prioritize time-sensitive cases Amsterdam, the Netherlands and Chicago, USA – Royal [...]